Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
J Intellect Disabil Res ; 66(4): 313-322, 2022 04.
Article in English | MEDLINE | ID: mdl-35191118

ABSTRACT

BACKGROUND: The world has suffered immeasurably during the COVID-19 pandemic. Increased distress and mental and medical health concerns are collateral consequences to the disease itself. The Genes to Mental Health (G2MH) Network consortium sought to understand how individuals affected by the rare copy number variations of 22q11.2 deletion and duplication syndrome, associated with neurodevelopmental/neuropsychiatric conditions, were coping. The article focuses on worry and disruptions in medical care caused by the pandemic. METHODS: The University of Pennsylvania COVID-19 Stressor List and care disruption questions were circulated by 22 advocacy groups in English and 11 other languages. RESULTS: A total of 512 people from 23 countries completed the survey; most were caregivers of affected individuals. Worry about family members acquiring COVID-19 had the highest average endorsed worry, whilst currently having COVID-19 had the lowest rated worry. Total COVID-19 worries were higher in individuals completing the survey towards the end of the study (later pandemic wave); 36% (n = 186) of the sample reported a significant effect on health due to care interruption during the pandemic; 44% of individuals (n = 111) receiving care for their genetic syndrome in a hospital setting reported delaying appointments due to COVID-19 fears; 12% (n = 59) of the sample reported disruptions to treatments; and of those reporting no current disruptions, 59% (n = 269) worried about future disruptions if the pandemic continued. Higher levels of care disruptions were related to higher COVID-19 worries (Ps < 0.005). Minimal differences by respondent type or copy number variation type emerged. CONCLUSIONS: Widespread medical care disruptions and pandemic-related worries were reported by individuals with 22q11.2 syndrome and their family members. Reported worries were broadly consistent with research results from prior reports in the general population. The long-term effects of COVID-19 worries, interruptions to care and hospital avoidance require further study.


Subject(s)
COVID-19 , DNA Copy Number Variations , Caregivers , Chromosomes , Humans , Pandemics
2.
Clin Genet ; 93(4): 762-775, 2018 04.
Article in English | MEDLINE | ID: mdl-28892148

ABSTRACT

Smith-Kingsmore syndrome (SKS) OMIM #616638, also known as MINDS syndrome (ORPHA 457485), is a rare autosomal dominant disorder reported so far in 23 patients. SKS is characterized by intellectual disability, macrocephaly/hemi/megalencephaly, and seizures. It is also associated with a pattern of facial dysmorphology and other non-neurological features. Germline or mosaic mutations of the mTOR gene have been detected in all patients. The mTOR gene is a key regulator of cell growth, cell proliferation, protein synthesis and synaptic plasticity, and the mTOR pathway (PI3K-AKT-mTOR) is highly regulated and critical for cell survival and apoptosis. Mutations in different genes in this pathway result in known rare diseases implicated in hemi/megalencephaly with epilepsy, as the tuberous sclerosis complex caused by mutations in TSC1 and TSC2, or the PIK3CA-related overgrowth spectrum (PROS). We here present 4 new cases of SKS, review all clinical and molecular aspects of this disorder, as well as some characteristics of the patients with only brain mTOR somatic mutations.


Subject(s)
Brain/metabolism , Megalencephaly/genetics , Smith-Lemli-Opitz Syndrome/genetics , TOR Serine-Threonine Kinases/genetics , Adolescent , Brain/physiopathology , Cell Proliferation/genetics , Child , Class I Phosphatidylinositol 3-Kinases/genetics , Developmental Disabilities/genetics , Developmental Disabilities/physiopathology , Female , Humans , Intellectual Disability/genetics , Intellectual Disability/physiopathology , Male , Megalencephaly/diagnostic imaging , Megalencephaly/physiopathology , Mutation , Neuronal Plasticity/genetics , Proto-Oncogene Proteins c-akt/genetics , Smith-Lemli-Opitz Syndrome/diagnostic imaging , Smith-Lemli-Opitz Syndrome/physiopathology , Tuberous Sclerosis Complex 1 Protein/genetics , Tuberous Sclerosis Complex 2 Protein/genetics
3.
Clin Immunol ; 179: 77-80, 2017 06.
Article in English | MEDLINE | ID: mdl-28302518

ABSTRACT

Mutations in PIK3R1 gene have been associated to two different conditions: a primary immunodeficiency, called APDS2, of recent description and SHORT syndrome. 47 patients with APDS2 have been reported to date, only one of them sharing both PIK3R1-related phenotypes. Here we describe two more patients affected by APDS2 and SHORT syndrome, which highlights that this association may not be so infrequent. We recommend that patients with mutations in PIK3R1 gene should be assessed by both clinical immunologists and clinical geneticists.


Subject(s)
Growth Disorders/genetics , Hypercalcemia/genetics , Immunologic Deficiency Syndromes/genetics , Metabolic Diseases/genetics , Nephrocalcinosis/genetics , Phosphatidylinositol 3-Kinases/genetics , Child , Class I Phosphatidylinositol 3-Kinases/genetics , Class Ia Phosphatidylinositol 3-Kinase , Humans , Infant , Male , Mutation , Primary Immunodeficiency Diseases
6.
Hum Mutat ; 31(5): E1332-47, 2010 May.
Article in English | MEDLINE | ID: mdl-20232352

ABSTRACT

Blepharophimosis Syndrome (BPES) is an autosomal dominant developmental disorder of the eyelids with or without ovarian dysfunction caused by FOXL2 mutations. Overall, FOXL2deletions represent 12% of all genetic defects in BPES. Here, we have identified and characterized 16 new and one known FOXL2 deletion combining multiplex ligation-dependent probe amplification (MLPA), custom-made quantitative PCR (qPCR) and/or microarray-based copy number screening. The deletion breakpoints could be localized for 13 out of 17 deletions. The deletion size is highly variable (29.8 kb - 11.5 Mb), indicating absence of a recombination hotspot. Although the heterogeneity of their size and breakpoints is not reflected in the uniform BPES phenotype, there is considerable phenotypic variability regarding associated clinical findings including psychomotor retardation (8/17), microcephaly (6/17), and subtle skeletal features (2/17). In addition, in all females in whom ovarian function could be assessed, FOXL2 deletions proved to be associated with variable degrees of ovarian dysfunction. In conclusion, we present the largest series of BPES patients with FOXL2 deletions and standardized phenotyping reported so far. Our genotype-phenotype data can be useful for providing a prognosis (i.e. occurrence of associated features) in newborns with BPES carrying a FOXL2 deletion.


Subject(s)
Blepharophimosis/genetics , DNA Copy Number Variations/genetics , Forkhead Transcription Factors/genetics , Gene Deletion , Mutation/genetics , Adolescent , Child, Preschool , Female , Forkhead Box Protein L2 , Genotype , Humans , Infant , Male , Middle Aged , Pedigree , Phenotype , Prognosis
7.
Placenta ; 30(6): 551-4, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19386358

ABSTRACT

Preeclampsia is the development of new-onset hypertension with proteinuria after 20 weeks of gestation. HELLP syndrome (haemolysis, elevated liver enzymes, and low platelet count) is a severe form of preeclampsia with high rates of neonatal and maternal morbidity. In recent years, loss of function of cdkn1c (a tight-binding inhibitor of G1 cyclin/cyclin-dependent kinase complexes and a negative regulator of cell proliferation) has been observed in several mouse models of preeclampsia. In this paper, we report on three women with HELLP/preeclampsia who had children with Beckwith Wiedemann syndrome, a complex genetic disorder characterised, among other findings, by overgrowth, omphalocele and macroglossia. All three children displayed mutations in CDKN1C predicted to generate truncated proteins. Two of the mutations were maternally inherited while the third was de novo. This finding suggests a fetal contribution to the maternal disease. To the best of our knowledge this is the first report of CDKN1C mutations in children born to women with preeclampsia/HELLP syndrome, thus suggesting the involvement of an imprinted gene in the pathophysiology of preeclampsia.


Subject(s)
Beckwith-Wiedemann Syndrome/genetics , Cyclin-Dependent Kinase Inhibitor p57/genetics , HELLP Syndrome/genetics , Pre-Eclampsia/genetics , Base Sequence , Beckwith-Wiedemann Syndrome/complications , DNA Mutational Analysis , Female , Genetic Predisposition to Disease , HELLP Syndrome/etiology , Humans , Infant, Newborn , Mutation/physiology , Pre-Eclampsia/etiology , Pregnancy
8.
Rev. esp. pediatr. (Ed. impr.) ; 65(1): 20-23, ene.-feb. 2009.
Article in Spanish | IBECS | ID: ibc-89351

ABSTRACT

La valoración y el estudio de un niño con retraso del desarrollo psicomotor /retraso mental debe hacerse de forma adecuada y de acuerdo con la recomendaciones vigentes basadas en la evidencia científica. Establecer un diagnóstico etiológico en estos casos permite aportar información muy valiosa para la atención y el seguimiento del niño y para el asesoramiento genético de su familia. Los elementos fundamentales de dicha valoración incluyen una historia clínica detallada, una exploración minuciosa, y un ejemplo razonado de las pruebas complementarias disponibles (AU)


The assessment of a child with developmental delay/mental retardation should be carried out following the current evidence-based recommendations. Establishing an etiological diagnosis allows to provide valuable information on the prognosis and clinical management of the child, and offer genetic counseling to his family. The main elements of the assessment include a detailed medical history, a thorough physical examination, and the judicious use of available tests and investigations (AU)


Subject(s)
Humans , Intellectual Disability/genetics , Psychomotor Disorders/genetics , Medical Records/standards , Child Development Disorders, Pervasive/genetics , Genetic Testing/methods , Genetic Counseling
9.
J Med Genet ; 45(2): 106-13, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18245390

ABSTRACT

BACKGROUND: A variety of abnormalities have been demonstrated at chromosome 11p15 in individuals with overgrowth and growth retardation. The identification of these abnormalities is clinically important but often technically difficult. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) is a simple but effective technique able to identify and differentiate methylation and copy number abnormalities, and thus is potentially well suited to the analysis of 11p15. AIMS: To customize and test an MS-MLPA assay capable of detecting and distinguishing the full spectrum of known 11p15 epigenetic and copy number abnormalities associated with overgrowth and growth retardation and to assess its effectiveness as a first line investigation of these abnormalities. METHODS: Five synthetic probe pairs were designed to extend the range of abnormalities detectable with a commercially available MS-MLPA assay. To define the normal values, 75 normal control samples were analysed using the customized assay. The assay was then used to analyse a "test set" of 24 normal and 27 abnormal samples, with data analysed by two independent blinded observers. The status of all abnormal samples was confirmed by a second technique. RESULTS: The MS-MLPA assay gave reproducible, accurate methylation and copy number results in the 126 samples assayed. The blinded observers correctly identified and classified all 51 samples in the test set. CONCLUSIONS: MS-MLPA robustly and sensitively detects and distinguishes epigenetic and copy number abnormalities at 11p15 and is an effective first line investigation of 11p15 in individuals with overgrowth or growth retardation.


Subject(s)
Chromosome Aberrations , Chromosomes, Human, Pair 11/genetics , Growth Disorders/genetics , Beckwith-Wiedemann Syndrome/genetics , DNA Methylation , Epigenesis, Genetic , Female , Gene Dosage , Genomic Imprinting , Humans , Male , Microsatellite Repeats , Molecular Probe Techniques , Nucleic Acid Amplification Techniques
10.
J Med Genet ; 45(6): 346-54, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18178631

ABSTRACT

BACKGROUND: Patients with a microscopically visible deletion of the distal part of the long arm of chromosome 1 have a recognisable phenotype, including mental retardation, microcephaly, growth retardation, a distinct facial appearance and various midline defects including corpus callosum abnormalities, cardiac, gastro-oesophageal and urogenital defects, as well as various central nervous system anomalies. Patients with a submicroscopic, subtelomeric 1qter deletion have a similar phenotype, suggesting that the main phenotype of these patients is caused by haploinsufficiency of genes in this region. OBJECTIVE: To describe the clinical presentation of 13 new patients with a submicroscopic deletion of 1q43q44, of which nine were interstitial, and to report on the molecular characterisation of the deletion size. RESULTS AND CONCLUSIONS: The clinical presentation of these patients has clear similarities with previously reported cases with a terminal 1q deletion. Corpus callosum abnormalities were present in 10 of our patients. The AKT3 gene has been reported as an important candidate gene causing this abnormality. However, through detailed molecular analysis of the deletion sizes in our patient cohort, we were able to delineate the critical region for corpus callosum abnormalities to a 360 kb genomic segment which contains four possible candidate genes, but excluding the AKT3 gene.


Subject(s)
Agenesis of Corpus Callosum , Chromosome Deletion , Chromosomes, Human, Pair 1/genetics , Adolescent , Adult , Child , Child, Preschool , Family , Female , Humans , Infant , Male , Syndrome
11.
Br J Cancer ; 90(1): 41-7, 2004 Jan 12.
Article in English | MEDLINE | ID: mdl-14710204

ABSTRACT

This study aimed to compare the impact of two versions of a psychoeducational written intervention on cancer worry and objective knowledge of breast cancer risk-related topics in women who had been living with an increased risk of familial breast cancer for several years. Participants were randomised to three conditions: scientific and psychosocial information pack (Group 1), scientific information pack only (Group 2) or standard care control (Group 3). They completed postal questionnaires at baseline (n=163) and 4 weeks (n=151). As predicted, there was a significant decrease in cancer worry for Group 1, but not Group 2. Objective knowledge significantly improved for both Group 1 and Group 2 as expected, but not Group 3. However, there was an unpredicted decline in cancer worry for Group 3. This study supports the value of a scientific and psychosocial information pack in providing up-to-date information related to familial risk of breast cancer for long-term attendees of a familial breast cancer clinic. Further research is warranted to determine how the information pack could be incorporated into the existing clinical service, thus providing these women with the type of ongoing psychosocial support that many familial breast cancer clinics are currently lacking.


Subject(s)
Anxiety , Breast Neoplasms/genetics , Breast Neoplasms/psychology , Genetic Predisposition to Disease , Patient Education as Topic , Social Support , Adult , Fear , Female , Humans , Middle Aged , Pedigree , Risk Factors
13.
Clin Dysmorphol ; 10(3): 165-70, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11446407

ABSTRACT

We report on three European cases of urofacial (Ochoa) syndrome. This entity was originally described in Colombian patients and very few cases have been reported from other countries. It is likely that they may be missed because of variability of the urinary problems and failure to recognize the characteristic facial grimacing. Establishing an early diagnosis has important consequences for the management and prognosis of urinary problems in these patients.


Subject(s)
Abnormalities, Multiple/pathology , Urinary Bladder, Neurogenic/pathology , Adult , Child , Europe , Facial Expression , Facies , Female , Humans , Male
14.
Prog. diagn. prenat. (Ed. impr.) ; 13(3): 154-168, mayo 2001. tab
Article in Es | IBECS | ID: ibc-21509

ABSTRACT

El Síndrome de Down es la cromosomopatía más frecuente en recién nacidos. Su diagnóstico prenatal es posible mediante un cariotipo fetal, pero el riesgo de aborto de los procedimientos empleados para conseguir muestras de tejido fetal, su coste y ciertos problemas organizativos impiden su aplicación a todas las gestantes. La población de gestantes es cribada para establecer grupos con un riesgo superior al resto a las que se les ofrecen estas técnicas diagnósticas. Los cribados del riesgo utilizan 3 tipos de variables: la edad materna, la detección de marcadores ecográficos y la medición de parámetros bioquímicos en sangre materna.Utilizando los casos de síndrome de Down recogidos por los sistemas de información de los 4 registros poblacionales de defectos congénitos existentes en España (Asturias, Barcelona, El Vallès y País Vasco) y pertenecientes al EUROCAT, se mide el uso de los métodos de cribado de riesgo, su sensibilidad para detectar los casos, la realización de pruebas invasivas y las interrupciones voluntarias del embarazo en estas 4 zonas durante el período 1996-1998.La sensibilidad global del cribado bioquímico fue de un 61 por ciento, con variaciones entre las distintas zonas. La ciudad de Barcelona es el área donde se utiliza más el cribado bioquímico y donde la sensibilidad de éste, así como del cribado ecográfico, son más elevadas. La ecografía obstétrica es un método de uso generalizado en las 4 zonas, apreciándose un incremento de la sensibilidad del cribado ecográfico a lo largo de los años del estudio en el conjunto de las 4 zonas.La proporción de casos a los que se les ha practicado una prueba invasiva es más elevada en Barcelona y depende directamente del mayor porcentaje de casos que han presentado un riesgo elevado. En la práctica totalidad de los casos diagnosticados prenatalmente en las 4 zonas se ha optado por la interrupción del embarazo (AU)


Subject(s)
Pregnancy , Female , Humans , Down Syndrome/diagnosis , Spain , Sensitivity and Specificity , Prenatal Diagnosis , Mass Screening , Risk Factors , Maternal Age
15.
Community Genet ; 4(4): 233-238, 2001 Jun.
Article in English | MEDLINE | ID: mdl-12107352

ABSTRACT

Objective: To describe and compare the information obstetricians and geneticists in five European countries report they would give following the prenatal diagnosis of Klinefelter syndrome. Methods: 388 obstetricians and 269 geneticists from Germany, the Netherlands, Portugal, Spain and the UK completed a brief questionnaire assessing two variables: the information they reported providing to parents following the prenatal diagnosis of Klinefelter syndrome (categorized as positive or negative); and their perceptions of the quality of life with the condition. Results: Geneticists were more likely than obstetricians to report providing more positive than negative information about Klinefelter syndrome than equal amounts of positive and negative information or more negative than positive information about the condition (excess positive information). Regardless of specialty, the information that health professionals reported providing was predicted by their perceptions of the quality of life with the condition, and the country from which they came. Those perceiving quality of life as greater were more likely to provide an excess positive information, as were health professionals from Germany and the UK. Conclusions: These results suggest that the information parents across Europe receive after the prenatal diagnosis of Klinefelter syndrome varies according to the specialty and country of the health professionals consulted, and their perceptions of quality of life with the condition. This variation seems to reflect personal, cultural and professional differences between health professionals. Copyright 2002 S. Karger AG, Basel

16.
Am J Hum Genet ; 66(5): 1504-15, 2000 May.
Article in English | MEDLINE | ID: mdl-10749657

ABSTRACT

The HLXB9 homeobox gene was recently identified as a locus for autosomal dominant Currarino syndrome, also known as hereditary sacral agenesis (HSA). This gene specifies a 403-amino acid protein containing a homeodomain preceded by a very highly conserved 82-amino acid domain of unknown function; the remainder of the protein is not well conserved. Here we report an extensive mutation survey that has identified mutations in the HLXB9 gene in 20 of 21 patients tested with familial Currarino syndrome. Mutations were also detected in two of seven sporadic Currarino syndrome patients; the remainder could be explained by undetected mosaicism for an HLXB9 mutation or by genetic heterogeneity in the sporadic patients. Of the mutations identified in the 22 index patients, 19 were intragenic and included 11 mutations that could lead to the introduction of a premature termination codon. The other eight mutations were missense mutations that were significantly clustered in the homeodomain, resulting, in each patient, in nonconservative substitution of a highly conserved amino acid. All of the intragenic mutations were associated with comparable phenotypes. The only genotype-phenotype correlation appeared to be the occurrence of developmental delay in the case of three patients with microdeletions. HLXB9 expression was analyzed during early human development in a period spanning Carnegie stages 12-21. Signal was detected in the basal plate of the spinal cord and hindbrain and in the pharynx, esophagus, stomach, and pancreas. Significant spatial and temporal expression differences were evident when compared with expression of the mouse Hlxb9 gene, which may partly explain the significant human-mouse differences in mutant phenotype.


Subject(s)
Abnormalities, Multiple/genetics , Embryo, Mammalian/metabolism , Genes, Homeobox/genetics , Homeodomain Proteins/genetics , Mutation/genetics , Sacrum/abnormalities , Amino Acid Sequence , Amino Acid Substitution/genetics , Animals , Codon, Terminator/genetics , Conserved Sequence/genetics , DNA Mutational Analysis , Growth Disorders/genetics , Homeodomain Proteins/chemistry , Homeodomain Proteins/metabolism , Humans , Male , Mice , Microsatellite Repeats/genetics , Molecular Sequence Data , Mutation, Missense/genetics , Phenotype , Sequence Deletion/genetics , Syndrome , Time Factors
17.
Am J Med Genet ; 95(4): 320-4, 2000 Dec 11.
Article in English | MEDLINE | ID: mdl-11186884

ABSTRACT

We report on a Spanish child with clinical manifestations suggestive of aminopterin syndrome sine aminopterin (ASSA), having unusual hair pattern, syndactyly of fingers and toes, low-set thumbs, high-arched palate, and mild developmental delay. However, he does not show other characteristic features of ASSA such as ossification defects of the cranium, microcephaly, hypertelorism, cryptorchidism, or growth retardation. Differences from and similarities with Juberg-Hayward syndrome are discussed. Because few patients have been reported so far it is difficult to distinguish between these two conditions, and it may be that they are variants of the same nosological entity. Consanguinity of parents in this family supports autosomal recessive inheritance of ASSA.


Subject(s)
Abnormalities, Multiple/genetics , Aminopterin , Folic Acid Antagonists , Child , Consanguinity , Facial Bones/abnormalities , Genes, Recessive , Hand Deformities, Congenital/genetics , Humans , Male , Skull/abnormalities , Syndrome
18.
J Med Screen ; 7(4): 169-74, 2000.
Article in English | MEDLINE | ID: mdl-11202581

ABSTRACT

OBJECTIVE: Evaluation of prenatal diagnosis of neural tube defects by ultrasound examination in unselected populations across Europe. SETTING: Prenatal ultrasound units in areas that report to contributing congenital malformation registers. METHODS: All cases with a suspected or confirmed neural tube defect and delivered within the 30 month study period were identified from 18 Congenital Malformation Registers from 11 European countries. Data on the pregnancy, prenatal scans, outcome of pregnancy, and information on different screening policies for each country were analysed. RESULTS: 670766 deliveries occurred in the area covered by the registers during the study period. A neural tube defect was diagnosed at delivery in 542 cases. In 84% of these, the lesion was isolated (166 anencephaly, 252 spina bifida, 35 encephalocele). Of the 166 isolated cases with anencephaly, 96% were correctly identified prenatally; one was missed on scan, two were wrongly diagnosed, and four were not scanned (sensitivity 98%). 84% of the prenatal diagnoses were made before 24 weeks' gestation; 86% of isolated anencephalic pregnancies were terminated. Of the 252 cases of isolated spina bifida, 171 (68%) were correctly identified prenatally; 66% of these before 24 weeks' gestation. The diagnosis was missed on scan in 60 cases and 21 were not scanned (sensitivity 75%). The mean reduction in birth prevalence because of termination of pregnancy for spina bifida was 49% (range 6-100%). There was a wide variation between centres in prenatal detection rate (33-100%), termination of pregnancy of prenatally diagnosed cases (17-100%), and gestation both at diagnosis and termination of pregnancy. CONCLUSION: A high prenatal detection rate for anencephaly was reported by all registers. There is a large variation in prenatal detection and termination rates for spina bifida between centres, reflecting differences both in policy and culture.


Subject(s)
Neural Tube Defects/diagnostic imaging , Prenatal Diagnosis , Ultrasonography, Prenatal/statistics & numerical data , Europe , Female , Humans , Neural Tube Defects/epidemiology , Pregnancy , Pregnancy Outcome/epidemiology , Spinal Dysraphism/diagnostic imaging , Spinal Dysraphism/epidemiology
19.
Cir Pediatr ; 12(1): 4-10, 1999 Jan.
Article in Spanish | MEDLINE | ID: mdl-10198542

ABSTRACT

OBJECTIVE: Collect the team experience in the treatment of children with cleft lip and palate, indicating the evolution of the team composition, advantages and improvement aspects, trying to transmit the need of team treatment. METHOD: The Bilbao cleft palate team was created in 1983, since then a cleft palate clinic, a parents group and a unit of velopharyngeal function has been developed. At present the team is composed by: pediatric reconstructor surgeon, speech therapist, orthodontist, dentist, pediatrician, ENT, maxillofacial surgeon, dismorphologyst, geneticist, nursing. RESULTS: One of the achievements has been the data unification, obtaining speech cephalometrics, photographic dental casts and video images with prospective view. At this time 403 cleft lip and palate children have been intervened, being essential the transdisciplinar team approach between surgeon, speech therapist and orthodontist. The importance of the team coordinator is pointed. The results of an audit of the two stage cleft palate closure in complete unilateral cleft lip and palate have obligated us to vary our surgical policy. The unresolved aspects are the lack of multidisciplinary team recognition at official level and the non existence of orthodontist in staff, without cost coverage of this treatment by public health system. CONCLUSIONS: In our experience the team treatment of cleft lip and palate has resulted in improvement of the clinic results, treatment protocols and training.


Subject(s)
Cleft Lip/surgery , Cleft Palate/surgery , Patient Care Team , Adolescent , Child , Child, Preschool , Humans , Infant , Infant, Newborn
20.
Am J Med Genet ; 77(3): 241-5, 1998 May 18.
Article in English | MEDLINE | ID: mdl-9605592

ABSTRACT

We report on a 4-year-old boy with craniometadiaphyseal dysplasia (CMDD), wormian bone type. Component manifestations include a large head with prominent forehead, skull changes showing multiple wormian bones, wide long tubular bones without the usual metaphyseal flare, wide and short tubular bones without the normal diaphyseal constriction, and wide ribs and clavicles. In addition to these findings, the propositus, his brother, his father, and a paternal aunt all have parietal protuberances, which seem not related to CMDD. Parental consanguineity supports the autosomal recessive transmission of the condition.


Subject(s)
Abnormalities, Multiple/classification , Bone and Bones/abnormalities , Craniofacial Abnormalities/classification , Abnormalities, Multiple/diagnosis , Abnormalities, Multiple/diagnostic imaging , Bone and Bones/diagnostic imaging , Bones of Upper Extremity/abnormalities , Bones of Upper Extremity/diagnostic imaging , Child, Preschool , Craniofacial Abnormalities/diagnosis , Craniofacial Abnormalities/diagnostic imaging , Genes, Recessive , Humans , Leg Bones/abnormalities , Leg Bones/diagnostic imaging , Male , Parietal Bone/abnormalities , Parietal Bone/diagnostic imaging , Radiography , Skull/abnormalities , Skull/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...